Patents by Inventor John A. Arcadi, deceased

John A. Arcadi, deceased has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7008961
    Abstract: Carcinoma is treated in a patient by administration of Rhodamine-123 (Rh-123) orally or by intravenous injection of a treatment solution of Rh-123, ethyl alcohol, dextrose, and water in an amount sufficient to effect in vivo destruction of cancer cells. The treatment solution is made by mixing a stock solution of Rh-123 in a solution of 95% ethyl alcohol and 5% water (by volume) with a solution of 5% (by weight) dextrose in water. For prostate cancer, treatment is controlled by measuring the level of prostate specific antigen (PSA), or prostate specific acid phosphatase in the blood of the patient.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: March 7, 2006
    Assignee: Huntington Medical Research Institutes
    Inventors: Doris M. Arcadi, legal representative, John A. Arcadi, deceased